gallium oxide has been researched along with fluvoxamine in 1 studies
| Studies (gallium oxide) | Trials (gallium oxide) | Recent Studies (post-2010) (gallium oxide) | Studies (fluvoxamine) | Trials (fluvoxamine) | Recent Studies (post-2010) (fluvoxamine) |
|---|---|---|---|---|---|
| 100 | 0 | 65 | 2,051 | 518 | 434 |
| Protein | Taxonomy | gallium oxide (IC50) | fluvoxamine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 0.54 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0038 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.54 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, H; Mitsutsuka, Y; Oyama, T; Serpone, N; Takamura, T; Tsukamoto, T | 1 |
1 other study(ies) available for gallium oxide and fluvoxamine
| Article | Year |
|---|---|
Photoassisted defluorination of fluorinated substrates and pharmaceuticals by a wide bandgap metal oxide in aqueous media.
Topics: Fluorides; Fluoxetine; Fluvoxamine; Gallium; Halogenation; Hydrogen-Ion Concentration; Kinetics; Oxidation-Reduction; Photolysis; Toluene; Ultraviolet Rays; Water | 2013 |